Evidence-based Optimization Study for TCM Syndrome Differentiation and Treatment Protocol of Stable Angina

iao'ning University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Meet the diagnostic criteria of Western medicine 2.4(2) Diagnostic criteria for stable angina, Diagnostic criteria for chest bi-syndrome with the syndrome of turbid phlegm and blood stasis and have no conflict with the efficacy of Danlou tablets;
•2. Aged from 35-75 years old;
•3. Those who have not taken any TCM preparation within two weeks;
•4. Those who can provide personal contact information and cooperate with the clinical trial visit and follow-up;
•5. Those who voluntarily participate in clinical observations and sign informed consent form.

•1. Stable angina complicated with valvular heart disease, various types of cardiomyopathy, malignant arrhythmia; The patients with heart failure whose NYHA cardiac function grading is III-IV;
•2. Stable angina complicated with hypertension without treatment or uncontrolled hypertension (Bp=180/110mmHg);
•3. Stable angina complicated with severe cerebrovascular disease;
•4. Stable angina complicated with severe pulmonary insufficiency (PaO2<60mmHg), endocrine and hematopoietic systems severe primary disease, Moderate to severe hepatic insufficiency(Transaminase levels are 3 times higher than the upper limit of normal) or Moderate to severe renal insufficiency(eGFR<60ml/min/1.73m2) or patients with newly diagnosed acute;
•5. Stable angina complicated with cerebrovascular disease during the past 3 months;
•6. Stable angina complicated with psychosis;
•7. Stable angina patient who are in the period of gestation or lactation;
•8. Stable angina patient participated in other clinical trials in the past 3 months;
•9. Patient with a life expectancy lower than 1 year;
•10. Allergic patients or patients who are allergic to TCM treatment;
•11. Those who are unwilling or unable to accept clinical follow-up.

发起方

iao'ning University of Traditional Chinese Medicine